Fluidigm will provide a status update on its Stem Cell Chip at the World Stem Cell Summit in Baltimore, Maryland from 21-23 September 2009.
The chip is expected to be on the market next year.
At the conference, Fluidigm's chief executive officer, Gajus Worthington, and chief scientific officer, Marc Unger, will meet with the press and answer questions.
Press meetings can be booked in advance.
The World Stem Cell Summit will bring together the stem-cell universe of researchers, Regen industry leaders, funders, medical philanthropies, policy-makers, advocates, educators and regulators to chart the future of regenerative medicine.
The comprehensive, multi-track programme will cover advanced science, commercial perspectives, disease progress reports and in-depth reviews of policy, law, ethics, regulatory issues and global economic development.
Many prominent stem-cell researchers using Fluidigm equipment will give presentations on their research.
These will include Dr Irving Weissman from the Institute for Stem Cell Biology and Regenerative Medicine (Stanford University, US) and Dr Toshio Suda from the Graduate School of Medicine, Keio University, Japan.
Historically, gene expression profiling of single cells, such as stem cells, has been difficult and expensive to perform.
Now, however, results from single-cell samples can be obtained easily and inexpensively using Fluidigm's Biomark System and Dynamic Array integrated fluidic circuits (IFCs).
Dynamic Array IFCs are suited for high-throughput cell-line studies to determine individual cell behaviour in a homozygous population.
A presentation describing this technology in more detail can be viewed at the company's website.
